Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy

por Laure Doisy, Arnaud Cimier, Aurélien Adypagavane, Jochen Walz, Thibault Marquette, Thomas Maubon, Stanislas Rybikowski, Sami Fakhfakh, Kevin Loverde, Nicolas Mottet, Jacques Irani, Eric Lechevallier, Dominique Rossi, Gwenaelle Gravis, Géraldine Pignot
Publicado 2021